Intensive blood pressure control has been suggested to reduce the risk of adverse cardiovascular events. However, the effect of intensive blood pressure control on cardiac conduction system disease has not been clarified. Our study in older patients with hypertension identified no effect of intensive blood pressure control on cardiac conduction system diseases.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kusumoto, F. M. et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation 140, e382–e482 (2019). This paper reports the evaluation and management of patients with cardiac conduction system diseases.
Bussink, B. E. et al. Right bundle branch block: prevalence, risk factors, and outcome in the general population: results from the Copenhagen City Heart Study. Eur. Heart J. 34, 138–146 (2013). This paper presents the association of hypertension with right bundle branch block.
Frimodt-Møller, E. K. et al. Association between intensive vs standard blood pressure control and incident left ventricular conduction disease: a post hoc analysis of the SPRINT randomized clinical trial. JAMA Cardiol 8, 612–616 (2023). A study that reports that intensive blood pressure control lowers the risk of left ventricular conduction disease.
Zhang, W. et al. Trial of intensive blood-pressure control in older patients with hypertension. N. Engl. J. Med. 385, 1268–1279 (2021). This paper reports that intensive blood pressure control reduces adverse cardiovascular event risk in older Chinese patients.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Zhao, S. et al. Incidence and prognosis of cardiac conduction system diseases in hypertension: the STEP trial. Nat. Aging https://doi.org/10.1038/s43587-024-00591-6 (2024).
Rights and permissions
About this article
Cite this article
Intensive blood pressure control does not lower risk of cardiac conduction system diseases. Nat Aging 4, 449–450 (2024). https://doi.org/10.1038/s43587-024-00605-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43587-024-00605-3
